insights_auto
Prečo akcie 4DX klesli 4,42%?
Preskúmať podrobnejšiechevron_right
4DX:ASX
4DMedical Ltd
2,16 AUD
arrow_downward
-4,42%(-0,100) 1 d.
20. 11., 16:12:01 GMT+11 · AUD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 4DX…
Otvoriť
2,25 AUD
Vysoká
2,30 AUD
Nízka
2,12 AUD
Trh. kap.
1,30 mld.
Priem. obj.
5,29 mil.
Objem
4,32 mil.
Max. za 52 týž.
7,55 AUD
Min. za 52 týž.
1,40 AUD
Výnosy na akciu
-0,38 AUD
Akcie v obehu
602,34 mil.
Počet zamestnancov
181
Otvoriť
2,25 AUD
Vysoká
2,30 AUD
Nízka
2,12 AUD
Trh. kap.
1,30 mld.
Priem. obj.
5,29 mil.
Objem
4,32 mil.
Max. za 52 týž.
7,55 AUD
Min. za 52 týž.
1,40 AUD
Výnosy na akciu
-0,38 AUD
Akcie v obehu
602,34 mil.
Počet zamestnancov
181
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
The Motley Fool
·
pred 56 minútami
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Yahoo Finance
·
pred 4 hodinami
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
Benzinga
·
pred 2 hodinami
S&P 500 Has Slumped Into a Correction as Goldman Sachs Panic Index Points to More Downside
Beinsure
·
pred 5 hodinami
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profil
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Informácie o subjekte 4DMedical Ltd
Generálny riaditeľAndreas Fouras
Zamestnanci181
Dátum založenia2013
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-